Weintraub Pharmaceutical is categorized under Medical Research in Rochester, NY and active since 2002.
Weintraub Pharmaceutical was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5416140 by the NAICS.
If you are seeking more information, feel free to contact Michael Weintraub at the company’s single location by writing to 70 Linden Oaks, Rochester, New York NY 14625 or by phoning (585) 271-8932. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Weintraub Pharmaceutical |
| Contact Person: | Michael Weintraub |
| Address: | 70 Linden Oaks, Rochester, New York 14625 |
| Phone Number: | (585) 271-8932 |
| Website Address: | weintraubpharmaceuticalconsulting.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5416140 |
| Share This Business: |
Weintraub Pharmaceutical was started in 2002 to provide professional Medical Research under the SIC code 8733 and NAICS code 5416140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Weintraub for inquiries that concern Weintraub Pharmaceutical by calling the company number (585) 271-8932, as your correspondence is most welcome. Additionally, the physical location of the single location of Weintraub Pharmaceutical can be found at the coordinates 43.12444,-77.52019 as well as the street address 70 Linden Oaks in Rochester, New York 14625.
For its online presence, you may visit Weintraub Pharmaceutical’s website at weintraubpharmaceuticalconsulting.com and engage with its social media outlets through on Twitter and on Facebook.